Clinical Study
Measurement of the Silver Ion Concentration in Wound Fluids after Implantation of Silver-Coated Megaprostheses: Correlation with the Clinical Outcome
Table 2
Infection group: clinical course prior to the implantation of a silver-coated megaprosthesis.
| Patient no. | Days until clinically definite infection | Pathogen of the infection | Revision operations | Days of hospitalization prior to SMP implantation | Days after SMP implantation |
| 1 | 36 | Staph. epi. | 7 | 66 | 31 | 2 | 18 | Enterobacter cloacae, Staph. epi. | 5 | 48 | 31 | 3 | 15 | Staph. epi. | 12 | 73 | 44 | 4 | 40 | Staph. epi, Enterococcus faec., Corynebacterium | 7 | 227 | 92 | 5 | 18 | Staph. epi, Enterococcus faec. | 5 | 74 | 24 | 6 | 13 | Staph. epi. | 4 | 47 | 27 | 7 | 8 | Enterobacter cloacae | 5 | 60 | 34 | 8 | 14 | Not demonstrable | 2 | 7 | 54 | 9 | 12 | Enterococcus faec. | 7 | 105 | 23 | 10 | 9 | Not demonstrable | 2 | 14 | 5 |
|
|
Staph: Staphylococcus; epi: epidermidis; feac: faecalis; SMP: silver-coated megaprosthesis.
|